Associate Director, Precision Medicine & Companion Diagnostics

About the role

Revolution Medicines is offering a highly visible opportunity for talented and motivated individual to join our Precision Medicine Companion Diagnostics team as an Associate Director, Companion Diagnostics within the Translational Medicine function, which supports CDx development across RevMed portfolio. Through both scientific and cross-functional leadership, individual is to implement global diagnostic strategies to enable and support the global development and commercialization of medically differentiated therapies. The successful candidate will have the opportunity to work in a fast-paced, highly collaborative environment and will be a key member of multidisciplinary development project teams. Required Skills, Experience and Education: Lead the development and implementation of diagnostic strategies through registration and launch for individual clinical studies and/or molecule program. Direct the development, outsourcing and validation of clinically applicable in vitro diagnostic assays through the development lifecycle of molecules, including design, implement and oversee diagnostic testing and registration strategy and timely communication with key internal and external stakeholders. Provide expertise to development project teams to ensure access to state-of-the-art approaches on appropriate diagnostic technologies (e.g. NGS-based tissue and ctDNA assays, PCR, immunohistochemistry), evaluating their scientific basis and clinical applicability, the validation status and any technical or statistical issues related to the proposed companion diagnostic assay. Oversee implementation of clinical trial assays at CRO laboratories for centralized testing supporting clinical trials. Monitors all scope or changes in study are timely implemented, including the development of the work order, costs and agreements. Lead joint development teams between RevMed and Dx partners to ensure cross-functional alignment of overarching development, regulatory and commercialization strategy, successful fit for purpose CDx development and that co-development timelines are met. Serve as subject matter expert in diagnostic regulation and support the interactions with global health authorities regarding companion diagnostics development and submissions. Preferred Skills: Highly experienced biomarker or diagnostics professional (MS and/or PhD) with a minimum of 7-10 years of relevant industry experience with expertise in oncology biomarker and/or companion diagnostic development. High level of initiative and ability to work independently with business awareness, hands on experience in IVD development processes and global in vitro diagnostic regulatory aspects related to companion diagnostic development. Experience with biomarker application in clinical trials and awareness of the challenges of implementing diagnostic technologies in the clinical setting. Experience with health authority interactions and regulatory submissions for pharmaceutical and/or in vitro diagnostics development globally. Excellent leadership skills including motivation and influencing without authority. Highly collaborative team player who fosters open communication and facilitates mutual understanding and cooperation between all stakeholders with excellent communication, analytical and organizational skills. Cross-functional experience in commercial and or medical aspects of companion diagnostics is a plus. #LI-Hybrid #LI-EM1 The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and signifi

Benefits

Additional Information

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at revolutionmedicines? Share your experience